204 related articles for article (PubMed ID: 29657587)
1. Impact of ranolazine on ventricular arrhythmias - A systematic review.
Bazoukis G; Tse G; Letsas KP; Thomopoulos C; Naka KK; Korantzopoulos P; Bazoukis X; Michelongona P; Papadatos SS; Vlachos K; Liu T; Efremidis M; Baranchuk A; Stavrakis S; Tsioufis C
J Arrhythm; 2018 Apr; 34(2):124-128. PubMed ID: 29657587
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine therapy in drug-refractory ventricular arrhythmias.
Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
[TBL] [Abstract][Full Text] [Related]
3. Suppression of frequent ventricular ectopy in a patient with hypertrophic heart disease with ranolazine: a case report.
Murdock DK; Kaliebe JW
Indian Pacing Electrophysiol J; 2011 May; 11(3):84-8. PubMed ID: 21556158
[TBL] [Abstract][Full Text] [Related]
4. The use of ranolazine in non-anginal cardiovascular disorders: A review of current data and ongoing randomized clinical trials.
Mihos CG; Krishna RK; Kherada N; Larrauri-Reyes M; Tolentino A; Santana O
Pharmacol Res; 2016 Jan; 103():49-55. PubMed ID: 26546970
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
Dagres N; Iliodromitis EK; Lekakis JP; Simitsis P; Karatzas D; Rallidis LS; Simeonidou E; Anastasiou-Nana M
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):254-9. PubMed ID: 24662415
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine Therapy in Cardiac Arrhythmias.
Pulford BR; Kluger J
Pacing Clin Electrophysiol; 2016 Sep; 39(9):1006-15. PubMed ID: 27358212
[TBL] [Abstract][Full Text] [Related]
7. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756
[TBL] [Abstract][Full Text] [Related]
8. Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
Kaliebe JW; Murdock DK
WMJ; 2009 Oct; 108(7):373-5. PubMed ID: 19886587
[TBL] [Abstract][Full Text] [Related]
9. A focus on antiarrhythmic properties of ranolazine.
Vizzardi E; D'Aloia A; Quinzani F; Bonadei I; Rovetta R; Bontempi L; Curnis A; Dei Cas L
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):353-6. PubMed ID: 22492919
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic properties of ranolazine--from bench to bedside.
Tzeis S; Andrikopoulos G
Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review.
Patel N; Kluger J
Cureus; 2018 May; 10(5):e2584. PubMed ID: 30009098
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias.
Shenasa M; Assadi H; Heidary S; Shenasa H
Card Electrophysiol Clin; 2016 Jun; 8(2):467-79. PubMed ID: 27261835
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
Yuriivna Osovska N; Vitaliivna Kuzminova N
Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
[TBL] [Abstract][Full Text] [Related]
14. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine in Cardiac Arrhythmia.
Saad M; Mahmoud A; Elgendy IY; Richard Conti C
Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
[TBL] [Abstract][Full Text] [Related]
16. Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients.
AlTurki A; Proietti R; Russo V; Dhanjal T; Banerjee P; Essebag V
Pharmacol Res; 2019 May; 143():133-142. PubMed ID: 30914300
[TBL] [Abstract][Full Text] [Related]
17. Classic herbal formula Zhigancao Decoction for the treatment of premature ventricular contractions (PVCs): a systematic review of randomized controlled trials.
Liu W; Xiong X; Feng B; Yuan R; Chu F; Liu H
Complement Ther Med; 2015 Feb; 23(1):100-15. PubMed ID: 25637158
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic properties of ranolazine: A review of the current evidence.
Gupta T; Khera S; Kolte D; Aronow WS; Iwai S
Int J Cardiol; 2015; 187():66-74. PubMed ID: 25828315
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine for the treatment of atrial fibrillation.
Rosa GM; Dorighi U; Ferrero S; Brunacci M; Bertero G; Brunelli C
Expert Opin Investig Drugs; 2015 Jun; 24(6):825-36. PubMed ID: 25872749
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.
Frommeyer G; Ellermann C; Dechering DG; Kochhäuser S; Bögeholz N; Güner F; Leitz P; Pott C; Eckardt L
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1214-1219. PubMed ID: 27283775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
